Anebulo Pharmaceuticals Stock Forecast

Sell candidate since Jun 18, 2026 Gain 1.37%

The Anebulo Pharmaceuticals, Inc. stock price gained 13.01% on the last trading day (Tuesday, 23rd Jun 2026), rising from $0.350 to $0.396. During the last trading day the stock fluctuated 0% from a day low at $0.396 to a day high of $0.396. The price has fallen in 5 of the last 10 days but is still up by 9.87% over the past 2 weeks. Volume fell on the last day by -2 thousand shares and in total, 500 shares were bought and sold for approximately $197.88 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -38.34% during the next 3 months and, with a 90% probability hold a price between $0.179 and $0.392 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ANEB Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 22, 2026, and so far it has risen 13.01%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Anebulo Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.418 and $0.438. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Anebulo Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.375 and $0.360. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Anebulo Pharmaceuticals, Inc. finds support just below today's level at $0.375. If this is broken, then the next support from accumulated volume will be at $0.360 and $0.350.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 4.27%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ANEB) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Anebulo Pharmaceuticals, Inc. to open at $0.396, and during the day (based on 14 day Average True Range), to move between $0.375 and $0.417, which gives a possible trading interval of +/-$0.0423 (+/-11.28%) up or down from last closing price. If Anebulo Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 11.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.400 (1.07%) than the support at $0.375 (5.22%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Anebulo Pharmaceuticals, Inc. stock A Buy?

Anebulo Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.484 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.396 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk